Professor Houhua Li and his team have made progress in the total synthesis of complex fungal meroterpenoids.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 453
- Publication type:
- Article
Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 5
Results: 11
1
2
Professor Yiguang Wang and his team developed a novel nano-delivery strategy for programmed regulation of tumor and lymph node immune microenvironment.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 451
- Publication type:
- Article
3
Professor Yiguang Wang and his team developed pH-Amplified CRET nanoparticles strategy for in vivo imaging of tumor metastatic lymph nodes.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 449, doi. 10.1002/anie.202102044
- Publication type:
- Article
4
Professor Yiguang Wang and his team developed new quantitative strategies for intracellular bioavailability of nanomedicines.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 447
- Publication type:
- Article
5
Professor Zhongjun Li and Professor Suwei Dong of Peking University School of Pharmaceutical Sciences awarded the Carbohydrate Chemistry Prize of Chinese Chemical Society.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 446
- Publication type:
- Article
6
Qualitation of Chuanxiong Rhizome essential oil and determination of 3-butylidenephthalide and ligustilide by GC-MS.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 434, doi. 10.5246/jcps.2021.05.034
- By:
- Publication type:
- Article
7
Antioxidant and antibacterial activities of the ethyl acetate extracts of endophytic fungi isolated from Ageratum conyzoides L.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 421, doi. 10.5246/jcps.2021.05.033
- By:
- Publication type:
- Article
8
Hypolipidemic effects of Alismatis Rhizoma decoction on the lipid profile in hyperlipidemia rats by RNA-sequencing.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 409, doi. 10.5246/jcps.2021.05.032
- By:
- Publication type:
- Article
9
Camrelizumab (SHR-1210), a humanized anti-PD-1 IgG4 mAb, exhibits superior anti-tumor activity and a favorable safety profile in preclinical studies.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 393, doi. 10.5246/jcps.2021.05.031
- By:
- Publication type:
- Article
10
Advances in anti-tumor effects and mechanisms of Pulsatilla Chinensis saponins and its monomers.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 381, doi. 10.5246/jcps.2021.05.030
- By:
- Publication type:
- Article
11
Nanomedicine for tumor therapy-current status and challenges.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 5, p. 359, doi. 10.5246/jcps.2021.05.029
- By:
- Publication type:
- Article